Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children

Commercially available Interferon-γ release assays (IGRAs), including the last-generation QuantiFERON TB-Plus (QFT-Plus), are effective in aiding the diagnosis of tuberculosis (TB) infection but cannot distinguish latent TB subjects from active TB patients. The aim of this study was to prospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonsenso, Danilo, Delogu, Giovanni, del Carmen Pereyra Boza, Maria, De Maio, Flavio, Palucci, Ivana, Martino, Laura, Pata, Davide, Sanguinetti, Maurizio, Valentini, Piero, Sali, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969014/
https://www.ncbi.nlm.nih.gov/pubmed/36847873
http://dx.doi.org/10.1007/s00431-023-04844-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969014/
https://www.ncbi.nlm.nih.gov/pubmed/36847873
http://dx.doi.org/10.1007/s00431-023-04844-1

Ejemplares similares